Upcoming Allied Market Research
Endobronchial Ultrasound Biopsy Device Market

Endobronchial Ultrasound Biopsy Device Market: Global Opportunity Analysis and Industry Forecast, 2023-2030 Market

Report Code: A10940
Pages: NA
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.


Endobronchial ultrasound (EBUS) is primarily used is diagnosis of the progression of lung cancer, its stages and assessment of further possible spread of the diseases to neighbouring body parts including lymph nodes. Endobronchial ultrasound (EBUS) technique has modernized over the time and enables the pulmonologists to sample tissues as well as fluid obtained from lungs and adjacent lymph nodes to visualize the structure surrounding the tracheobronchial tree.  The EBUS and endobronchial ultrasound-assisted transbronchial needle aspiration (EBUS TBNA) are recently developed advanced techniques and show promising results in evaluation of pulmonary nodules, and diagnosis of lung infections. Additionally, endobronchial ultrasound biopsy has applications in identification of various diseases including tuberculosis and chronic pulmonary obstructive disorder that negatively impact the lungs and other respiratory organs. For instance, enlarged lymph nodes and abnormal development of masses in the chest and many others. Endobronchial ultrasound biopsy is a minimally invasive technique for collection of tissue samples, majorly from lungs.

COVID – 19 scenario analysis: 

  • The COVID-19 pandemic has emerged as a humanitarian as well as economic crisis, creating strain on the society and affecting millions of people and businesses
  • Industry closures and people are asked to stay in their homes which has cause taken a huge toll in terms of money and economic growth
  • Over 4 million people affected globally, with 300 thousand losing their lives due to SARS-CoV-2
  • Healthcare organizations are already working in battle mode, preparing new plans to respond growing COVID-19 patients, right from sourcing rapid diagnosing kits to sufficient PPE kits for workers
  • Due to diversion of medical field towards treating COVID-19, the funding to R&D activities related to for endobronchial ultrasound biopsy has been reduced and this segment have to face negligence subsequently causing negative impact on endobronchial ultrasound biopsy market
  • However, the higher prevalence of SARS-CoV-2 virus in people with lung disorders is attributed with higher mortality and morbidity rates, which would soar the demand for endobronchial ultrasound biopsy devices in the market

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

The factors including technological development in EBUS devices, consumer preference towards minimally invasive surgeries, growing prevalence of respiratory diseases like tuberculosis and high number of people suffering from lung cancer are driving the global endobronchial ultrasound biopsy market. While low cost of manufacturing in emerging countries is offering new growth avenues to the endobronchial ultrasound biopsy market for expansion in near future. Furthermore, rising geriatric population coupled with higher rates of lung infections and other respiratory ailments requiring endoscopic ultrasound procedures are the factors that fuel the growth of this market.

Certain studies in areas related to lung ailments and respiratory disorders concluded that endobronchial ultrasound is affordable and cost-effective in comparison with other therapies as it reduces the requirement for costly, invasive and highly morbid procedures like mediastinoscopy and thoracotomy. Additionally, EBUS offer better images that provides the physicians and pulmonologists in visualization of several complicated areas and enable more access to these difficult-to-reach areas which helps in efficient diagnosis and biopsy.

On the contrary, endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is an advanced technique, but it requires expertise and experience in implementing it effectively. Evidence-based procedures for training the pulmonologists in the area of EBUS-TBNA are necessary, however; as of now, no such accepted or standard techniques exist for assessing EBUS technical skills and competencies which would hamper the growth for this market. In addition to this, the high cost of these medical devices and dearth of proper reimbursement policies in emerging economies can potentially restrain the market.

Increasing patient preference towards minimally invasive surgeries

Endobronchial ultrasound biopsy being a minimally invasive procedure is gaining popularity as an alternative to open surgeries that are invasive in nature, thereby shifting the patient preference towards minimally invasive surgeries owing to certain attributes such as minor incisions, lesser pain, tissue damage, prevention of surgical scars, rapid recovery and lesser stay at the healthcare facilities in comparison with invasive surgeries These techniques being increasingly used across the medical field as they benefit both the medical professionals and patients as they minimize the discomfort caused to patients due to open surgeries and mostly, avoid surgeries and physical harm. The advantages such as minor complications in rare cases, less pain and lower surgery costs pertaining to use of endobronchial ultrasound biopsy is likely to facilitate the market growth over the next few years.

Increasing incidences of lung cancer to propel the growth

Rising incidences of cancers and geriatric population are the factors that go hand-in-hand and are on rise since past few decades. The growth of cancers considering the current growth rate is estimated to have around 27.5 million new cancer cases annually by 2040 around the world. This represents an immense increase of 61.7% from the year 2018 and is further estimated to grow in males with an increasing rate of 67.6 comparatively higher than females estimated to increase at a rate of 55.3%. Additionally, lung cancer being 3rd major cause of cancer in the UK, resulting in 13% of new cases of cancer. Similarly in India, approximately 67,795 new reported cancer cases were seen in 2018. Due to high of cancer, and increasing population base suffering with lung cancer, the demand for endobronchial ultrasound biopsy procedures is expected to surge in the near future, thereby augment the market growth.

 Key benefits of the report:

  • This study presents the analytical depiction of the global endobronchial ultrasound biopsy devices market along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global endobronchial ultrasound biopsy devices market share.
  • The current market is quantitatively analyzed to highlight the global endobronchial ultrasound biopsy devices market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global endobronchial ultrasound biopsy devices market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Endobronchial ultrasound biopsy devices Market research report:

  • What are the leading market players active in the endobronchial ultrasound biopsy devices market?
  • What the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?

Endobronchial Ultrasound Biopsy Device Market: Global Opportunity Analysis and Industry Forecast, 2020-2027 Report Highlights

Aspects Details
By Product
  • Biopsy Forceps
  • Cytology Brushes
  • Biopsy Needles
  • Transbronchial Aspiration Needles
  • Spray
  • Catheters
  • Others
By Application
  • Lung Cancer Diagnosis
  • Lung Infection Diagnosis
  • Others
By End User
  • Hospitals
  • Specialty Cancer Care Centers
  • Diagnostic Centers
  • Ambulatory Surgical Centers
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, Uk, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (Japan, China, India, Australia, South Korea, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Veran Medical Technologies, CONMED Corporation, Medi-Globe Corporation, Clinodevice, Olympus Corporation, Boston Scientific Corporation, Cook Group Incorporated., Simbionix USA Corporation, FUJIFILM Corporation, Medtronic plc
Other Players Siemens Healthcare

Loading Table Of Content...

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Purchase Options

Call or Email Us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Endobronchial Ultrasound Biopsy Device Market

Start reading.
This Report and over 71,230+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise

  • $9,870
  • Unlimited
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

Related Reports

Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of the scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time for readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of the scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save the time of readers